Industry Insights · Industry Bulletin Digest
Polymer Medical Device Bulletin 2025 Issue 4 digest: device law and a materials challenge
This year-end issue is worth watching on three threads: legislation, materials breakthroughs and market size.
Legislation upgrade: a Device Management Law
Regulators conducted legislative research on a Medical Device Management Law, meaning regulation may rise from a 'regulation' to a 'law' level, firming up the industry's long-term compliance framework.
Materials push: open competition
The second batch of the biomedical-materials innovation 'open competition' shortlist was announced, reflecting sustained national investment in biomedical materials — a choke-point direction.
Market and quality
- 2025 market size projected at RMB 1.22 trillion;
- adjustments to consumable-use rules;
- GMP Announcement No. 107 (2025) and the single-use sterile catheter review guideline consultation.
The BIO angle
FAQ
What does a Device Management Law mean?
Regulation may rise from a 'regulation' to a 'law' level, making the long-term compliance framework firmer and more authoritative.
What is 'open competition' (jiebang guashuai)?
A national R&D organization method: key tasks are posted openly and capable units 'take the banner' to deliver, focused on choke-point areas like biomedical materials.
The most citable market figure here?
2025 market size projected at RMB 1.22 trillion — a key basis for industry scale.
Related reading
- Polymer Medical Device Bulletin 2025 Issue 1 Digest: Regulatory Reform and Annual Data | BIO Insights
- Polymer Medical Device Bulletin 2025 Issue 3 Digest: Procurement Changes and EU Exports | BIO Insights
- Polymer Medical Device Bulletin 2026 Issue 1 Digest: Annual Highlights and UDI Progress | BIO Insights
Note: an original analysis compiled from public industry information; figures and conclusions per official/original sources. Not investment advice.
Building in China's medical-device market?
From advanced medical silicone/polymers to material selection, regulatory and supply, BIO helps global and local partners move from selection to landed supply in China.